Market News AIOpen the app

On Wednesday, significant stock price increases were observed for Estee Lauder, Moderna, Merck, and several other major companies.

MarketRead the original at benzinga.com
Good for EL

Reported better-than-expected Q4 results and FY27 guidance, leading to a significant stock price increase.

EL · Estee Lauder Companies Inc

AI read · Good for EL

The AI's read

Estee Lauder reported better-than-expected Q4 results and gave FY27 sales guidance with the midpoint above estimates, and the stock popped hard intraday. The beat includes adjusted EPS 39c vs. 32c and sales $3.63B vs. $3.54B, plus organic sales +5%. The market already moved, with shares up ~15.5% and RSI ~68.6, so a big chunk of the good news is priced in. That reduces asymmetric upside but the guidance lift and sizable jump still leave room for follow-through if execution continues. Our take leans bullish because the company delivered both beat and higher guidance, which is rare for large-cap consumer names. Position sizing should be cautious given the fast move and choppy market regime; treat any new exposure as compact and nimble.

MRK · Merck & Co Inc

AI read · Good for MRK

The connection

Announced positive topline results from a Phase 3 trial, contributing to a notable stock price increase.

MRNA · Moderna Inc

AI read · Good for MRNA

The connection

Also reported positive trial results in collaboration with Merck, resulting in a substantial stock price increase.

Get alerts for EL

Follow Estee Lauder Companies Inc (EL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for EL
Free on the App Store and Google Play, or on the web.